Global Market Study on High Content Screening: Pharmaceutical and Healthcare Segment to Remain Dominant Through 2025


High Content Screening Market
  • Published On : Dec-2016 |
  • Pages : 125 Pages |
  • Format :

This report by Persistence Market Research on the global high content screening market for the period 2016–2025 presents an outlook of the market across the globe. The primary objective of the report is to offer updates on market opportunities in the global high content screening market. The report is categorically divided into four sections namely, by product type, by application, by end-use, and by region, to understand and offer insights on the global high content screening market. The report provides analysis of the global high content screening market in terms of market value (US$ Mn) and shipment (Units).

The report starts with an overview of the global high content screening market. This section includes PMR’s analyses of key trends, drivers, and restraints from the supply, demand, and macroeconomic perspectives. Impact analysis of key growth drivers based on the weighted average model are included in the report to better equip and arm clients with crystal-clear and decision-making insights. The section that follows analyses the market on the basis of product type and presents the forecast in terms of shipment and value for the next nine years. On the basis of product type, the global high content screening market has been segmented into:

  • Equipment
  • Consumables
  • Software
  • Services

Next section included in the report is on the basis of application that analyzes the market and presents the forecast in terms of shipment and value for the next nine years. On the basis of application, the global high content screening market has been segmented into:

  • Primary and secondary screening
  • Target identification and validation
  • Toxicity studies
  • Compound profiling
  • Others

Another section included in the report is on the basis of end-use that analyzes the market and presents the forecast in terms of volume and value for the next nine years. On the basis of end-use, the global high content screening market has been segmented into:

  • Pharmaceutical and healthcare
  • Biotechnology
  • Educational institutions
  • Government organizations
  • Independent contract research organizations (CROs)

The following section of the report includes analysis of the global high content screening market on the basis of region. The global high content screening market is segmented into four key regions:

  • North America
  • Western Europe
  • Asia Pacific
  • Middle East and Africa

In the final section of the report, the HCS market competitive landscape is included to provide report audiences with a dashboard view of the market players and company analysis, based on categories of providers across the value chain, their presence in the high content screening product portfolio and key differentiators. Some of the major market players featured in this section, include:

  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company (BD)
  • PerkinElmer Inc.
  • GE Healthcare
  • Merck Millipore Corporation

Research Methodology

To deduce market size, the report considered the average adoption rate of high content screening technology across geographies. Furthermore, data points such as regional split and market split by product type, by application, by end-use, and qualitative inputs from primary respondents have been incorporated to arrive at suitable market estimates. The forecast presented in the report evaluates the total revenue that is expected to be generated across the high content screenings market over forecast period (2015–2025). When developing the market forecast, the starting point involved sizing up the current market, which forms the basis for forecasting how the market is anticipated to take shape during the forecast period. Given the characteristics of the market, PMR triangulated the data on the basis of various analysis based on both supply side and demand side. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them at the end of the forecast period.

It is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyze the market on the basis of key parameters, such as Year-on-Year (Y-o-Y) growth, to understand the predictability of the market and identify the right opportunities. All these sub-segments or categories have been analyzed in terms of Basis Points (BPS) to understand the individual segment’s relative contribution to market growth. This detailed level of information is important for identification of many key trends in the high content screening market.

Another key feature of this report is the analysis of the high content screening market by region, product type, application, end-use, sample type and its revenue forecast in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global high content screening market. In order to understand key growth segments in terms of growth and performance of the high content screening market, Persistence Market Research developed a market attractiveness index. The resulting index should help providers identify real market opportunities.

High content screening enables identification of small molecules, peptides, and other micro-molecules associated with human cells. HCS plays a vital role in biological research activities and drug discovery. With surging drug discovery projects, toxicity studies, and other research ventures, the demand for enhanced imaging has been on the rise since the past few years. This will primarily sustain the demand for high content screening technique and instrument over the next decade.

PMR assesses the global high content screening market for a nine-year forecast period, 2016-2025. The market will register the revenues worth US$ 1.24 Bn by 2016 end, which are expected to grow at a CAGR of 6.1% by the end of 2025. Over the forecast period, the HCS installation is anticipated to reach 988 units.

Market Dynamics

In addition to enhanced toxicity studies, burgeoning drug discovery processes worldwide are also likely to fuel the demand for novel technologies in cell analysis, boosting the sales of high content screening instrument thereby. A large number of ongoing life science research activities, coupled with growing governmental support to research is anticipated to further propel the market for HCS. Moreover, research-based pharmaceuticals and biotechnology companies, especially in developing economies, will continue to accelerate the market growth by 2025 end. Sustained sales of mid-end and high-end HCS instrument will remain a key factor contributing a major share of revenues to the global market for high content screening over the next decade.

Increased emphasis on secondary screening of cells for toxicity studies, will also play a significant role in bolstering the demand for high content screening technology. Moreover, assessment of risks in chronic diseases is another factor that is likely to escalate the demand, as it employs the drug discovery process trough high content screening. Despite higher costs, HCS instruments are predicted to gain higher traction in research and educational institutions. Development of automated systems for cell separation and scalability analysis will also create opportunities for HCS instrument manufacturers. Growing demand for highly efficient therapeutic cell purification protocols is expected to further drive the market for high content screening technology.

Segment Analysis

By product, the global market for HCS is segmented into cell imaging and analysis equipment, consumables, software, and services. The cell imaging and analysis equipment segment is predicted to be a major segment. Software segment will also register a remarkable CAGR during 2016-2025.

By application, there are five key segments viz. primary and secondary screening, target identification and validation, toxicity studies, compound profiling, and others. Primary and secondary screenings segment is anticipated to register the highest consumption of HCS instruments over 2016-2025. While this segment will expand at a CAGR of 6%, the revenues generated from it will possibly account for over 36% share of the market. Toxicity studies segment is projected to surpass a value of US$ 406 Mn by 2025 end, expanding at a higher CAGR of 7.1%.

By end-use, the market can be classified as pharmaceutical and healthcare, biotechnology, educational institutions, government organizations, and independent CROs. Pharmaceutical and healthcare segment will remain dominant throughout the forecast period, followed by biotechnology segment.

Regional Analysis

By region, the global high content screening market is segmented into seven key markets - North America, Western Europe, Asia Pacific (APAC), and Middle East and Africa (MEA). Western Europe is foreseen to remain the largest revenue shareholder, accounting for a value of around US$ 720.5 Mn by 2025 end. This region will expand at a healthy CAGR of 6.1% over the forecast period. North America is likely to retain the second largest market position with over 31% market share in 2025. APAC is expected to witness significant growth through to 2025.

high content screening market

Key Players Analysis

New product development for cell analysis is currently a top priority for key players in the global high content screening market. Some of the leading companies participating in the market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), PerkinElmer Inc., GE Healthcare, Merck Millipore Corporation, Olympus Corporation, Thorlabs Inc., Danaher Corporation (Molecular Devices), Sysmex Corporation, and Yokogawa Electric Corporation.

Company Profiles

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer Inc.
  • Merck Millipore Corporation
  • Danaher Corporation (Molecular Devices)
  • Yokogawa Electric Corporation
  • Sysmex Corporation
  • Thorlabs, Inc.
  • Others.
Back To Top